Status:
COMPLETED
Impact of Pharmacist Intervention on Disease Knowledge, Rehabilitation and Medication Adherence, Treatment Induced Direct Cost, Health-related Quality of Life and Satisfaction in Patients With Rheumatoid Arthritis
Lead Sponsor:
Universiti Sains Malaysia
Collaborating Sponsors:
Clifton Central Hospital
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this study was to evaluate effectiveness of pharmacist intervention in improving disease knowledge, adherence to treatment, health related quality of life and direct cost of treatment...
Detailed Description
Rheumatoid arthritis is a chronic inflammatory disease that mainly affects the joints and results in pain, swelling and decreased mobility. The disease over the course of time, leads to joint deformit...
Eligibility Criteria
Inclusion
- Types of participants Inclusion criteria
- The patients who meet the following criteria would be invited to participate in our study:
- Patients suffering from rheumatoid arthritis diagnosed with rheumatoid arthritis according to the 2010 ACR/EULAR criteria.
- Patients diagnosed with RA based on above mentioned criteria for at least 3 months prior to invitation.
- Patients aged above 18 years
- Patients visiting out-patient clinics only. Before enrolling in the study, patients attended a study explanation session and provided a written consent to participate.
- Exclusion criteria
- Patients were excluded from the study if they had any of the following conditions:
- Patients with musculoskeletal illnesses other than rheumatoid arthritis
- Patients with a recent history of surgery or planned surgery for rheumatoid arthritis
- Patients with more than three co-morbidities
- Patients with any lab abnormalities, being treated for liver or kidney disease
- Patients who have had a severe infection and have completed antibiotic course in the last week
- Patients with advanced cardiovascular disease, severe allergies or a rare disease
- Patients who are currently participating in other clinical trial or have participated in the last three months.
- Pregnant patients, planning to become pregnant, breast feeding and females with other gynecological issues were not included.
Exclusion
Key Trial Info
Start Date :
November 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
714 Patients enrolled
Trial Details
Trial ID
NCT03827148
Start Date
November 17 2018
End Date
July 1 2019
Last Update
March 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clifton Central Hospital
Karachi, Sindh, Pakistan, 75600